Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Birmingham Alabama

A clinical research study for the treatment of Alzheimer's Disease

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Research Center
Phoenix Arizona 85006

Are you concerned about memory loss?

Xenoscience Inc.
Phoenix Arizona 85013

Clinical trial for Early Alzheimers

Research Center
Sun City Arizona 85351

Are you concerned about memory loss?

View More ▼

UPDATED

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with Mild Cognitive Impairment or Alzheimer's Disease

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Phoenix Arizona

A clinical research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85004

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85018

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85005

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

Phoenix Arizona 85004

A clinical trial to evaluate treatments using Bryostatin 1 and Placebo for patients with Alzheimer's Disease, Moderately Severe Alzheimer's Disease

Phoenix Arizona 85006

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Phoenix Arizona 85004

A Phase 2 clinical study for patients with Alzheimer's Disease

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Alzheimer's Disease, Traumatic Brain Injury or Depression

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Tucson Arizona

A clinical research study for the treatment of Alzheimer's Disease

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Tucson Arizona 85704

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

Tucson Arizona 85718

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Arkansas

Research Center
Fayetteville Arkansas 72703

Are you concerned about memory loss?

View More ▼

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Little Rock Arkansas 72211

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Springdale Arkansas 72764

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

California

NEW

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

This study is a Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease.

Pharmacology Research Institute, Encino
Encino California 91316

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6124 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Pharmacology Research Institute, Encino
Encino California 91316

Study of an investigational medication for the treatment of Alzheimer's Disease